n-(3-Ethylphenyl)-1,3-benzothiazol-2-amine, 97%, 250mg

GC-Kapillarsäule ROTI®Cap-XLB, L 30m, Ø innen 0,25mm, Filmdicke 0,25µm, 1 Stück

2-(Methylsulfonyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 5g

1-(4-Chloro-3-methylbenzyl)piperidin-4-one, 5g

H-Pro-NMe2, 95%, 250mg

2,3-Dihydro-1-benzofuran-7-ylboronic acid, 95.0%, 1g

N-Fmoc-tranexamic acid, 95.0%, 5g

N-(6-acetyl-3-methoxy-2-methylphenyl)-4-isopropylthiazole-2-carboxamide, 98%, 100mg

1-(4-(2-Chloroacetyl)piperazin-1-yl)cyclohexane-1-carbonitrile, 98%, 250mg

(R)-1-(naphthalen-1-yl)-N-(3-(trifluoromethyl)benzyl)ethan-1-amine, 98%, 1g

4-BROMO-3-CHLOROPHENYLACETIC ACID, 95.0%, 250mg

4-Bromo-2-fluoropyridine, 98.0%, 100g

2-Biphenylisocyanate, 95.0%, 5g